The severity of megaloblastic anemia should be judged according to its clinical manifestations and the degree of anemia, and the prognosis is generally good after standardized treatment.
Megaloblastic anemia is an anemia caused by a deficiency of folic acid or vitamin B12 (VitB12) or by certain drugs that affect nucleotide metabolism, resulting in an impairment of DNA synthesis in the cell nucleus. The prognosis is usually better after treatment of the primary cause and treatment with folic acid and vitamin B12 supplementation.
It is generally caused by decreased intake, increased demand (such as increased folic acid demand in women during pregnancy), and impaired absorption (such as diarrhea, inflammation of the small intestine, etc., which affects the absorption of folic acid, and gastrectomy, gastric acid and pepsin deficiency, etc., which affects the absorption of VitB12).
The main manifestations of megaloblastic anemia include anemia symptoms such as pallor, fatigue, dizziness, palpitations, and in severe cases, complete blood cell reduction, recurrent infections and bleeding; digestive symptoms such as oral mucosa, beef-like tongue, lack of appetite, malaise, abdominal distension, and other digestive symptoms; as well as psychiatric symptoms such as irritability, paranoia, depression, insomnia, memory loss, delusions and even psychosis, personality perversion, and other psychiatric symptoms.
Megaloblastic anemia should go to regular hospitals and be treated under the guidance of professional doctors.